Gastroduodenal Mucosa and Dyspeptic Symptoms in Arthritic Patients during Chronic Nonsteroidal Anti‐Inflammatory Drug Use

The American Journal of Gastroenterology

Volumn 82, Issue 11, 1987, Pages 1153-1158

  Larkai, Edwin N ^a,b   Smith, J Lacey ^a,b   Lidsky, Martin D ^a,b   Graham, David Y ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; INDOMETACIN; NAPROXEN; PIROXICAM; SULINDAC; TOLMETIN;

ARTHRITIS; DIAGNOSIS; DUODENUM ULCER; DYSPEPSIA; GASTROINTESTINAL TOXICITY; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; RHEUMATOID ARTHRITIS; STOMACH MUCOSA; STOMACH ULCER;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; DUODENOSCOPY; DYSPEPSIA; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINAL MUCOSA; MALE; MIDDLE AGE; PEPTIC ULCER;

EID: 0023604786     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1987.tb05246.x     Document Type: Article

References (50)

1. Non‐steroidal analgesic and anti‐inflammatory agents
2. Nonsteroidal antiinflammatory drugs
3. Variations in responses to non‐steroidal anti‐inflammatory drugs
4. Indomethacin in rheumatoid arthritis: Clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders
5. Plasma concentration of phenylbutazone and its therapeutic effect: Studies in patients with rheumatoid arthritis
6. Transsynovial distribution of ibuprofen in arthritic patients
7. Factors determining efficacy of NSAIDs
8. The argument for aspirin as the NSAID of choice in the management of rheumatoid arthritis
9. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of healthy volunteers
10. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti‐inflammatory agents on the gastric and duodenal mucosa
11. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric‐coated aspirin on gastric and duodenal mucosa
12. Nonsteroidal anti‐inflammatory effects of sulindac sulfoxide and sulfide on gastric mucosa
13. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti‐inflammatory agents
14. Effects of flubiprofen and aspirin on the gastric and duodenal mucosa
15. Comparison of gastrointestinal effects of aspirin and fenoprofen
16. Comparative effects of aspirin and naproxen on gastric mucosa
17. Gastric adaptation occurs with aspirin administration in man
18. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa
19. A gastroscopic and histological double‐blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa
20. Effect of diclofenac and naproxen on gastroduodenal mucosa
21. Effect of aspirin on the human stomach in normals: Endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration
22. A double‐blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers
23. Gastroscopic evaluation of anti‐inflammatory agents
24. Dyspepsia in patients with rheumatoid arthritis
25. Incidence of gastric lesions in patients with rheumatoid disease on chronic aspirin therapy
26. Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers
27. Gastroscopy in elderly patients
28. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy
29. Effect of anti‐inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment, Scand
30. Side‐effects of piroxicam (feldene), A one‐year material of 103 reports from Norway
31. Long‐term efficacy and safety of piroxicam in the treatment of rheumatoid arthritis
32. Peptic ulcer and piroxicam
33. Major gastrointestinal ulceration in association with piroxicam
34. Peptic ulcer during treatment of rheumatoid arthritis with cortisone derivatives
35. Upper gastrointestinal endoscopy in normal asymptomatic volunteers
36. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families: comparison with a computer‐matched family sample, Scand
37. Asymptomatic ulcers and erosions occur in normal volunteer populations
38. Minimization of gastric damage with enteric‐coated aspirin granules compared to buffered aspirin
39. Reduction in gastric mucosal hemorrhage and ulceration with chronic high‐level dosing of enteric‐coated aspirin granules two and four times a day
40. Gastroscopic Findings after treatment with enteric‐coated and plain naproxen tablets in healthy subjects
41. Use of anti‐inflammatory drugs by patients admitted with small and large bowel perforations and hemorrhage
42. Intestinal perforation associated with osmotic slow release indomethacin capsules
43. Sulindac: A potential renal‐sparing nonsteroidal anti‐inflammatory drug
44. Effects of sulindac and indomethacin on renal prostaglandin synthesis
45. Renal effects of nonsteroidal anti‐inflammatory agents
46. Nonsteroidal antiinflammatory drugs and renal function
47. Healing of peptic ulcers during continuing anti‐inflammatory drug therapy in rheumatoid arthritis
48. Healing of aspirin‐associated peptic ulcer disease despite continued salicylate ingestion
49. Cimetidine for peptic ulcer in patients with arthritis
50. The arthritic ulcer: A retrospective study of peptic ulceration in patients with rheumatoid arthritis